138 related articles for article (PubMed ID: 33628692)
1. Gastrointestinal Perforation With an Intraluminal Stent and Bevacizumab use in Advanced Metastatic Colorectal Cancer.
Akeel N; Toonsi WA
Cureus; 2021 Jan; 13(1):e12831. PubMed ID: 33628692
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Gastrointestinal Perforation in a Patient with Colon Cancer and Stent Placement during Bevacizumab Treatment, Alleviated with Conservative Therapy].
Chida S; Matsumoto S; Inoue N; Takenoshita S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2148-50. PubMed ID: 26805293
[TBL] [Abstract][Full Text] [Related]
3. Intestinal perforation in colorectal cancers treated with bevacizumab (Avastin).
Choi YI; Lee SH; Ahn BK; Baek SU; Park SJ; Kim YS; Shin SH
Cancer Res Treat; 2008 Mar; 40(1):33-5. PubMed ID: 19688063
[TBL] [Abstract][Full Text] [Related]
4. [A bowel perforation with metallic stent placement for advanced rectal cancer during bevacizumab-based chemotherapy].
Yoshinami T; Ichiba M; Hayashi S; Yamamoto K; Shibuya M; Higashimoto Y
Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):625-31. PubMed ID: 20379097
[TBL] [Abstract][Full Text] [Related]
5. [A case of delayed colonic perforation after metallic stent placement for advanced descending colon cancer during bevacizumab-based chemotherapy].
Tanaka I; Hisai H; Miyazaki E; Ono M; Maeda Y; Sato M; Kawasaki R; Gyobu H; Nakajima S; Yamada S; Muramatsu H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2319-21. PubMed ID: 22202368
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
[TBL] [Abstract][Full Text] [Related]
7. Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents.
Pacheco-Barcia V; Mondéjar R; Martínez-Sáez O; Longo F; Moreno JA; Rogado J; Donnay O; Santander C; Carrato A; Colomer R
Clin Colorectal Cancer; 2019 Sep; 18(3):e287-e293. PubMed ID: 31262698
[TBL] [Abstract][Full Text] [Related]
8. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer.
Fang K; Wang J; Yuan J; Sui C; Zhi J; Xia Y; Sun M
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1952. PubMed ID: 38258341
[TBL] [Abstract][Full Text] [Related]
10. Colorectal stenting for palliation and as a bridge to surgery: A 5-year follow-up study.
Bayraktar B; Ozemir IA; Kefeli U; Demiral G; Sagiroğlu J; Bayraktar O; Adali G; Ozcelik A; Tortum OB
World J Gastroenterol; 2015 Aug; 21(31):9373-9. PubMed ID: 26309363
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.
Chen HH; Lin JK; Chen JB; Chuang CH; Liu MC; Wang JY; Changchien CR
Asia Pac J Clin Oncol; 2018 Feb; 14(1):61-68. PubMed ID: 28906589
[TBL] [Abstract][Full Text] [Related]
12. Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX Trial.
Matsui T; Nagata N; Hirata K; Okazaki S; Sato S; Nakamura M; Kim H; Oba K; Sakamoto J; Mishima H
Anticancer Res; 2016 Jul; 36(7):3437-43. PubMed ID: 27354605
[TBL] [Abstract][Full Text] [Related]
13. XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study.
Rosati G; Avallone A; Aprile G; Butera A; Reggiardo G; Bilancia D
Cancer Chemother Pharmacol; 2013 Jan; 71(1):257-64. PubMed ID: 23100174
[TBL] [Abstract][Full Text] [Related]
14. Delayed colonic perforation following stent placement for colorectal obstruction: a description of two cases with stent palliation.
Vahedian Ardakani J; Rashidian N; Arabpoor Dahooei B; Keramati MR; Arab MR; Shafiei Sabet A
Acta Med Iran; 2013; 51(10):720-3. PubMed ID: 24338147
[TBL] [Abstract][Full Text] [Related]
15. When a good call leads to a bad connection: colovesical fistula in colorectal cancer treated with bevacizumab.
Chen J; Smalligan RD; Nadesan S
Hosp Pract (1995); 2016 Aug; 44(3):120-2. PubMed ID: 27309405
[TBL] [Abstract][Full Text] [Related]
16. [A Case Describing Treatment with FOLFIRI plus Bevacizumab after a Self-Expandable Metallic Stent Placement for Local Recurrence].
Yokoyama M; Yamazaki K; Kodama M; Kondo S; Yoshida A; Miyahara Y
Gan To Kagaku Ryoho; 2018 May; 45(5):863-865. PubMed ID: 30026453
[TBL] [Abstract][Full Text] [Related]
17. Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab.
Ushida Y; Shinozaki E; Chin K; Suenaga M; Takahari D; Ozaka M; Ogura M; Ichimura T; Wakatsuki T; Yamaguchi K
Case Rep Oncol; 2018; 11(2):601-608. PubMed ID: 30283317
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
[TBL] [Abstract][Full Text] [Related]
19. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
20. A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy.
Hashida H; Satake H; Kaihara S
Case Rep Oncol; 2017; 10(1):81-85. PubMed ID: 28203168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
